Twist Bioscience Corporation Share-based Payment Arrangement, Amount Capitalized
Twist Bioscience Corporation (TWST) reported Share-based Payment Arrangement, Amount Capitalized of -$100.00 thousand for the 3-month period ending 2023-06-30, per its 10-Q filed 2024-08-02.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement
us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount · last filed 2024-08-02
- Twist Bioscience Corporation share-based payment arrangement, amount capitalized for the quarter ending 2023-06-30 was -$100.00K.
- Twist Bioscience Corporation share-based payment arrangement, amount capitalized for the quarter ending 2023-03-31 was $200.00K.
| Period end | Share-based Payment Arrangement, Amount Capitalized 3 month | Share-based Payment Arrangement, Amount Capitalized 6 month | Share-based Payment Arrangement, Amount Capitalized 9 month |
|---|---|---|---|
| 2023-06-30 | -$100.00K 10-Q · filed 2024-08-02 | $100.00K derived: sum of 2 quarters · filed 2024-08-02 | -$500.00K 10-Q · filed 2024-08-02 |
| 2023-03-31 | $200.00K 10-Q · filed 2024-05-02 | $400.00K 10-Q · filed 2024-05-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |